37 Paid Clinical Research Studies in Chapel Hill, North Carolina

Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.

Phase1

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

The body has different ways of fighting infection and disease. No single way is perfect for fighting cancer. This research study combines two different ways of fighting disease: an

πŸ“ Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Subjects will receive either ATLCAR.CD30.CCR4 or the ATLCAR.CD30.CCR4 product in combination with an ATL product encodin

View Study & Checklist βž”
Observational / Diagnostic

Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine

This study is designed to test the feasibility and preliminary efficacy of a continuous glucose monitor (CGM)-augmented food is medicine (FIM) intervention for adults with type 2 d

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Following the 12-week intervention, all participants will receive both FIM intervention and wear real-time CGM for a 4-w

View Study & Checklist βž”
Phase1

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

The body has different ways of fighting infection and disease. No single way is effective at fighting cancer. This research study combines two different ways of fighting disease: a

πŸ“ Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Lymphodepleting Regimen Subjects will receive a lymphodepleting regimen of fludarabine 25 mg/m2/day administered IV ove

View Study & Checklist βž”
Phase4

Dupilumab for Eosinophilic Esophagitis With Severe Strictures

The purpose of this research study is to determine how well an FDA-approved drug, dupilumab, works to treat patients with severe strictures and active Eosinophilic Esophagitis (EoE

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ If eligible and enrolled into the study, participants will receive weekly subcutaneous (under the skin) injections of du

View Study & Checklist βž”
Observational / Diagnostic

Impact of Financial Incentives

This trial will look at the impact of clinic-level financial incentives to improve provider communication and increase HPV vaccine uptake. Some clinics will receive communication t

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Observational / Diagnostic

Water From Bottles to Establish Strong Teeth

The waterBEST study is a proof-of-concept, randomized, double-masked, placebo controlled, parallel group study evaluating dental caries-preventive effects of fluoridated bottled wa

πŸ“ Division of Pediatric and Public Health, UNC Adams School of Dentistry β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Phase1

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

This research study combines 2 different ways of fighting disease: antibodies and T cells. Both antibodies and T cells have been used to treat patients with cancers, and both have

πŸ“ Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ These subjects will receive one of two assigned dose levels of rimiducid with their second standard of care treatment.

View Study & Checklist βž”
Phase1 / Phase2

Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL

The body has different ways of fighting infection and disease. No single way seems perfect for fighting cancer. This research study combines two different ways of fighting disease:

πŸ“ Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Eligibility Criteria Prior to Lymphodepletion for Second Infusion (Optional) Note: Subjects may receive a second infusio

View Study & Checklist βž”
Observational / Diagnostic

mPATH-Cloud for Colorectal Cancer Screening

This study assesses the effectiveness of colorectal cancer (CRC) screening intervention, mobile Patient Technology for Health (mPATHβ„’-Cloud), compared to usual care among subjects

πŸ“ Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Observational / Diagnostic

PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcology

The purpose of this study is to investigate how collecting information about treatment-related side effects directly from patients can help manage the side effects associated with

πŸ“ Lineberger Comprehensive Cancer Center β€” Chapel Hill, North Carolina

πŸ’΅ Participants will receive a follow-up phone call or message from the team when participants have new or worsening sympto

View Study & Checklist βž”
Phase2

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

The goal of this study is to learn whether children, adolescents, and young adults with newly diagnosed high-grade osteosarcoma can be safely discharged from the hospital at slight

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Participants will receive standard chemotherapy, meet study-defined discharge criteria, be monitored for side effects, a

View Study & Checklist βž”
Observational / Diagnostic

The PharmFIT Study

This study will conduct a randomized controlled trial to assess the impact of a pharmacy-based FIT intervention, Pharmacy-based FIT (PharmFIT), on colorectal cancer screening (CRC)

πŸ“ Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Phase2

Revumenib, Azacitidine, and VENetoclax in Newly Diagnosed KMT2A-Rearranged AML

This study is testing a new treatment combination called RAVEN, which includes revumenib, azacitidine, and venetoclax, in patients who are newly diagnosed with a specific type of a

πŸ“ Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Induction Phase: Patients will receive treatment for up to 3 cycles.

View Study & Checklist βž”
Observational / Diagnostic

Optimization of Dietary Adherence in a Mobile Weight Loss Intervention

The goal of this study is to test multiple individual treatment components added to a 6-month standard mobile behavioral weight loss program that are intended to help participants

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ All participants will receive the Core 6-month behavioral weight loss program, which is a comprehensive intervention tha

View Study & Checklist βž”
Observational / Diagnostic

Daily Upgrade Trial

This study evaluates the acute and chronic effects of an essential amino acid supplement (Daily Upgrade EAA+) on metabolomics, amino acid kinetics, metabolic rate, body composition

πŸ“ Applied Physiology Laboratory β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Interventional Protocol

Personalized Environment and Genes Study

Despite the overwhelming focus on genetic and genomic causes of human disease over the past two decades, it has been estimated that genetics is currently known to explain only 20%

πŸ“ University of North Carolina β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Observational / Diagnostic

Healthy Living Anson Study

The goal of this randomized delayed control intervention research study is to see if participants who receive education and healthy prepared meals improve the quality of their diet

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

View Study & Checklist βž”
Observational / Diagnostic

Caring for the Carer

The purpose of the present study is to investigate the acceptability and feasibility of implementing a novel, Cognitive Behavioral Therapy (CBT) intervention to caregivers and supp

πŸ“ University of North Carolina at Chapel Hill β€” Chapel Hill, North Carolina

πŸ’΅ Participants will receive the individual therapy intervention once per week or bi-weekly, for 20 sessions, over the cour

View Study & Checklist βž”